Support Xconomy Detroit →
Top Entrepreneurs' Advice →
Boston Angel Investors →
Incubator Guide →
Chairman and CEO, Nanobiosym Diagnostics Inc.
Former CEO, Calistoga Pharmaceuticals
Co-Founder and CEO, Wetpaint
Co-Founder, VP of Technology, Entropic Communications
VP of Research & Policy, Ewing Marion Kauffman Foundation
VP of Venture Capital, Pfizer Inc.
Nobel Laureate, Professor of Biology, Caltech
President, University of Texas Medical Branch in Galveston
As 2011 nears its midpoint, we’re now in a position to see how the recession-era and follow-on consolidation trends have impacted middle-market and growth-stage mergers and acquisitions.
Large blue-chip technology companies,... Read more »
[Editor's note: This post was co-authored by Moss Adams partners Ken Salgado (based in Southern California) and Derek Dowsett (Silicon Valley).]
It’s early in the year, and although there... Read more »
At the end of 2009, we were optimistic that the M&A markets would pick up and become the key near-term source of liquidity for investors before any real momentum in the... Read more »
It’s obvious that the financial downturn has negatively impacted innovation. Lack of investment has meant fewer startups, and lack of capital for liquidity events and exits has pushed a listless market... Read more »
The second half of 2009 provided a good measure of optimism, easing some of the pain investors felt toward the end of 2008 and in early 2009. The stock market has... Read more »
Seattle · 04/22/142:45 pm - 6:00 pm
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2014, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.